Targeting of HSF1 as a therapeutic approach to inhibit the progression of hormone-dependent breast cancer.

2021/43/B/NZ5/01850

Keywords

Descriptors

  • NZ5_003: Patogeneza chorób człowieka
  • NZ5_007: Leczenie chorób człowieka

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr hab. Natalia Vydra

Number of co-investigators in the project: 8

Call

OPUS 22 – announced on 2021-09-15

Amount awarded
1 218 780 PLN
Project start date
2022-06-27
Project end date
2027-01-26
Project duration
55 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. An Increase in HSF1 Expression Directs Human Mammary Epithelial Cells toward a Mesenchymal Phenotype

    Authors:
    Natalia Vydra, Agnieszka Toma-Jonik, Patryk Janus, Katarzyna Mrowiec, Tomasz Stokowy, Magdalena Głowala-Kosińska, Damian Robert Sojka, Magdalena Olbryt, Wiesława Widłak
    Academic press:
    Cancers (Basel) (year: 2023, volume: 15, pages: 4965), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/cancers15204965 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski